Project Grant HT94252410629
Award Date 6/15/24
Completion Date 7/31/27
Dollars Obligated $1.2M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Fairfax, VA, USA
Similar Awards
- The Department of Defense's Defense Health Agency awarded a $1,330,054 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Regents of the University of California, San Francisco (UCSF). The grant supports the "CLINICAL VALIDATION AND IMPLEMENTATION OF A HOST-PATHOGEN-BASED DIAGNOSTIC ASSAY FOR EARLY LYME DISEASE AND OTHER TICK-BORNE INFECTIONS" project, with a performance period from July 1, 2024 to June 30, 2027. As a leading academic medical...
- The Defense Health Agency awarded Duke University a $1,255,621 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to develop diagnostic and therapeutic agents targeting Borrelia burgdorferi, the causative agent of Lyme disease. The grant, with a performance period from September 15, 2024 to September 14, 2027, will enable Duke to conduct innovative biomedical research aimed at improving health outcomes for military service members and the broader public. As a...
- Federal Grant Award Summary The University of Maryland, College Park received a $1,292,721 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the development of novel small-molecule therapeutics against Lyme disease. The award, effective September 30, 2025, with a completion date of September 29, 2028, supports a three-year research initiative conducted through the university's Office of Research Administration &...
- The Defense Health Agency awarded The Johns Hopkins University a $818,750 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Immune System Disturbances After Borrelia Burgdorferi Infection". The project will take place over 3 years from August 1, 2023 to July 31, 2026. As a leading research university, Johns Hopkins has extensive experience providing biomedical research, public health initiatives, and scientific analysis to...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Leland Stanford Junior University a $436,236 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) on August 1, 2025, for a two-year project period concluding July 31, 2027. The grant supports development of an epitaxial graphene-based biosensor designed to enable rapid and sensitive detection of active Borrelia burgdorferi (Bb) infections, the causative...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded UCLA a $739,332 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to develop a machine learning approach using patient registry data to identify and reveal neurological manifestations of persistent Lyme disease. The three-year award, effective June 1, 2025, through May 31, 2028, will be performed at UCLA's Los Angeles, California location. This research initiative leverages advanced...
- Federal Project Grant Award Summary Worcester Polytechnic Institute received a $542,500 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the three-year period from July 1, 2025 through June 30, 2028. The award supports development of MSHOST (a novel human in vitro genome-wide association platform) to advance understanding of Borrelia burgdorferi pathogenesis and genetic susceptibility to Lyme disease. This research...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Tufts University School of Medicine a $165,000 project grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 1, 2025, with a completion date of June 30, 2027. This award funds the development of an improved transposon mutagenesis system for comprehensive genetic analysis of Borrelia burgdorferi, the causative agent of Lyme disease. The primary deliverables...
- Federal Project Grant Award Summary Microbiotix, Inc. received a $1,023,646 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period August 1, 2025 through July 31, 2027. The award supports the development of oxadiazole inhibitors targeting bacterial nonstop ribosome rescue mechanisms as potential treatments for tick-borne diseases, specifically Lyme disease and tularemia, with applications for military personnel,...
- Federal Grant Award Summary Tufts University School of Medicine, doing business as Trustees of Tufts College, received a $3.315 million Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded September 19, 2025, with an ultimate completion date of August 31, 2029. The grant supports research investigating the microbial determinants of excessive inflammation and severe Lyme disease, with...